Australia markets closed

PMV Pharmaceuticals, Inc. (PMVP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1000-0.0500 (-2.33%)
At close: 04:00PM EDT
2.1000 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-65,102
-68,960
-73,317
-57,846
-34,440
Depreciation & amortisation
1,448
1,257
315
307
318
Stock-based compensation
12,053
12,375
10,195
5,340
1,933
Change in working capital
1,438
5,427
-568
4,123
-845
Accounts payable
-629
235
-389
191
-1,230
Other working capital
-58,229
-56,619
-71,744
-47,920
-32,887
Other non-cash items
-364
-370
243
955
143
Net cash provided by operating activities
-56,829
-55,657
-63,760
-46,571
-32,739
Cash flows from investing activities
Investments in property, plant and equipment
-1,400
-962
-7,984
-1,349
-148
Purchases of investments
-227,526
-220,539
-229,199
-256,845
-14,512
Sales/maturities of investments
154,902
170,956
235,815
114,610
42,571
Net cash used for investing activities
-74,024
-50,545
-1,368
-143,584
27,911
Cash flows from financing activities
Common stock issued
-
35,121
0
0
223,176
Net cash used provided by (used for) financing activities
35,565
35,577
958
2,022
292,972
Net change in cash
-95,288
-70,591
-64,170
-188,133
288,144
Cash at beginning of period
143,764
109,119
173,289
361,422
73,278
Cash at end of period
48,476
38,528
109,119
173,289
361,422
Free cash flow
Operating cash flow
-56,829
-55,657
-63,760
-46,571
-32,739
Capital expenditure
-1,400
-962
-7,984
-1,349
-148
Free cash flow
-58,229
-56,619
-71,744
-47,920
-32,887